BRPI0911961A2 - agente terapêutico para dor - Google Patents
agente terapêutico para dorInfo
- Publication number
- BRPI0911961A2 BRPI0911961A2 BRPI0911961A BRPI0911961A BRPI0911961A2 BR PI0911961 A2 BRPI0911961 A2 BR PI0911961A2 BR PI0911961 A BRPI0911961 A BR PI0911961A BR PI0911961 A BRPI0911961 A BR PI0911961A BR PI0911961 A2 BRPI0911961 A2 BR PI0911961A2
- Authority
- BR
- Brazil
- Prior art keywords
- pain
- therapeutic agent
- therapeutic
- agent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008128735 | 2008-05-15 | ||
PCT/JP2009/002109 WO2009139168A1 (ja) | 2008-05-15 | 2009-05-14 | 疼痛治療薬 |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0911961A2 true BRPI0911961A2 (pt) | 2015-10-13 |
Family
ID=41318543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0911961A BRPI0911961A2 (pt) | 2008-05-15 | 2009-05-14 | agente terapêutico para dor |
Country Status (18)
Country | Link |
---|---|
US (2) | US20110059956A1 (pt) |
EP (1) | EP2305654B1 (pt) |
JP (1) | JP5533649B2 (pt) |
KR (1) | KR101614966B1 (pt) |
CN (1) | CN102026987B (pt) |
AU (1) | AU2009247440B2 (pt) |
BR (1) | BRPI0911961A2 (pt) |
CA (1) | CA2723623C (pt) |
DK (1) | DK2305654T3 (pt) |
ES (1) | ES2550790T3 (pt) |
HU (1) | HUE026358T2 (pt) |
MX (1) | MX2010012425A (pt) |
PT (1) | PT2305654E (pt) |
RU (1) | RU2486900C2 (pt) |
SG (2) | SG189814A1 (pt) |
TW (1) | TWI459948B (pt) |
WO (1) | WO2009139168A1 (pt) |
ZA (1) | ZA201007839B (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103374000B (zh) * | 2012-04-13 | 2015-11-11 | 中国科学院广州生物医药与健康研究院 | 嘧啶并二氮杂卓类化合物及其药用组合物和应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5484917A (en) * | 1993-06-16 | 1996-01-16 | Pfizer Inc. | Substituted tetrahydrobenzazepinones |
AU721081B2 (en) * | 1996-12-10 | 2000-06-22 | Zeria Pharmaceutical Co., Ltd. | 1,5-benzodiazepine derivatives |
EP1234818B1 (en) * | 1999-12-02 | 2004-09-08 | Zeria Pharmaceutical Co., Ltd. | Calcium salts of 1,5-benzodiazepine derivatives, process for producing the salts and drugs containing the same |
DK1839662T3 (da) | 2005-01-19 | 2010-05-10 | Zeria Pharm Co Ltd | Antitumormiddel |
-
2009
- 2009-05-13 TW TW098115909A patent/TWI459948B/zh not_active IP Right Cessation
- 2009-05-14 CA CA2723623A patent/CA2723623C/en not_active Expired - Fee Related
- 2009-05-14 WO PCT/JP2009/002109 patent/WO2009139168A1/ja active Application Filing
- 2009-05-14 DK DK09746375.6T patent/DK2305654T3/en active
- 2009-05-14 PT PT97463756T patent/PT2305654E/pt unknown
- 2009-05-14 SG SG2013031281A patent/SG189814A1/en unknown
- 2009-05-14 EP EP09746375.6A patent/EP2305654B1/en not_active Not-in-force
- 2009-05-14 MX MX2010012425A patent/MX2010012425A/es active IP Right Grant
- 2009-05-14 SG SG10201502377RA patent/SG10201502377RA/en unknown
- 2009-05-14 ES ES09746375.6T patent/ES2550790T3/es active Active
- 2009-05-14 CN CN200980117150.8A patent/CN102026987B/zh not_active Expired - Fee Related
- 2009-05-14 HU HUE09746375A patent/HUE026358T2/en unknown
- 2009-05-14 KR KR1020107025219A patent/KR101614966B1/ko not_active IP Right Cessation
- 2009-05-14 JP JP2010511888A patent/JP5533649B2/ja not_active Expired - Fee Related
- 2009-05-14 AU AU2009247440A patent/AU2009247440B2/en not_active Ceased
- 2009-05-14 BR BRPI0911961A patent/BRPI0911961A2/pt not_active Application Discontinuation
- 2009-05-14 RU RU2010151433/15A patent/RU2486900C2/ru not_active IP Right Cessation
- 2009-05-14 US US12/991,179 patent/US20110059956A1/en not_active Abandoned
-
2010
- 2010-11-02 ZA ZA2010/07839A patent/ZA201007839B/en unknown
-
2014
- 2014-09-24 US US14/495,047 patent/US20150038495A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2305654A1 (en) | 2011-04-06 |
US20150038495A1 (en) | 2015-02-05 |
WO2009139168A1 (ja) | 2009-11-19 |
JP5533649B2 (ja) | 2014-06-25 |
CN102026987B (zh) | 2014-03-12 |
ES2550790T3 (es) | 2015-11-12 |
HUE026358T2 (en) | 2016-06-28 |
KR20110021763A (ko) | 2011-03-04 |
SG10201502377RA (en) | 2015-05-28 |
TW200946122A (en) | 2009-11-16 |
RU2486900C2 (ru) | 2013-07-10 |
CA2723623A1 (en) | 2009-11-19 |
AU2009247440B2 (en) | 2013-09-26 |
SG189814A1 (en) | 2013-05-31 |
EP2305654B1 (en) | 2015-10-14 |
US20110059956A1 (en) | 2011-03-10 |
DK2305654T3 (en) | 2016-01-11 |
JPWO2009139168A1 (ja) | 2011-09-15 |
KR101614966B1 (ko) | 2016-04-22 |
EP2305654A4 (en) | 2012-03-21 |
TWI459948B (zh) | 2014-11-11 |
ZA201007839B (en) | 2012-02-29 |
AU2009247440A1 (en) | 2009-11-19 |
CN102026987A (zh) | 2011-04-20 |
PT2305654E (pt) | 2016-02-04 |
MX2010012425A (es) | 2010-12-17 |
RU2010151433A (ru) | 2012-06-20 |
CA2723623C (en) | 2016-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013011874A2 (pt) | compostos e métodos para tratar dor | |
BRPI0821145A2 (pt) | Agente terapêutico para prurido | |
BR112013013311A2 (pt) | agente terapêutico de indução de citotoxicidade | |
EP2119444A4 (en) | THERAPEUTIC AGENT FOR PAIN | |
BRPI0813725A2 (pt) | Métodos e composições para tratamento de doenças | |
BRPI0810081A2 (pt) | Agente terapêutico e agente diagnóstico para doenças cerebrais de disfunção mitocondrial | |
BRPI0916931A2 (pt) | agentes terapêuticos | |
BRPI0908026A2 (pt) | Métodos para o tratamento de doenças do intestino | |
BRPI0821660A2 (pt) | Combinações de agentes terapêuticos para tratamento de câncer | |
BRPI1007636A2 (pt) | Composição farmacêutica, forma de dosagem, método para a preparação da composição farmacêutica, método de preparação da forma de dosagem e método de tratamento da dor | |
BRPI0920030A2 (pt) | agente de oclusão do tecido | |
BRPI0921321A2 (pt) | métodos para o tratamento de indwcções e tumores | |
BR112013014583A2 (pt) | composição farmacêutica, e, métodos para o tratamento de inflamação, para o tratamento da dor, e para preparar 3-metanossulfonilpropionitrila | |
BRPI0909251A2 (pt) | Composição para o cuidado da pele | |
BR112012001819A2 (pt) | métodos para tratamento de dor | |
BRPI0716592A2 (pt) | Composição para cuidado da pele | |
BR112012031836A2 (pt) | combinação farmacêutica para o tratamento da dor | |
BRPI0908428A2 (pt) | uso de ranozalina para tratar a dor. | |
BR112012000502A2 (pt) | terapia de combinação para o tratamento de diabetes | |
DK2144905T3 (da) | Terapeutiske midler | |
BRPI0813670A2 (pt) | Compostos para tratamento | |
BRPI1014528A2 (pt) | compostos para tratamento de inflamação e dor | |
BRPI0816712A2 (pt) | terapia de intervalo para o tratamento de tinnitus | |
BRPI0906606A2 (pt) | Tratamento terapêutico para condições do pulmão. | |
BRPI0923688A2 (pt) | compostos e métodos para o tratamento de dor e outras doenças |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |